Obesity paradox, obesity orthodox, and the metabolic syndrome: An approach to unity

Molecular Medicine

Volumn 22, Issue , 2016, Pages 873-885

  Roth, Jesse ^a,c   Sahota, Navneet ^a,b   Patel, Priya ^a,b   Mehdi, Syed F ^a   Wiese, Mohammad M ^a   Mahboob, Hafiz B ^a   Bravo, Michelle ^a   Eden, Daniel J ^a   Bashir, Muhammad A ^a   Kumar, Amrat ^a   Alsaati, Farah ^a   Kurland, Irwin J ^c   Brima, Wunnie ^a,c   Danoff, Ann ^d   Szulc, Alessandra L ^c   Pavlov, Valentin A ^a   Tracey, Kevin J ^a   Yang, Huan ^a  

^a Northwell Health   (United States)

^b NEW YORK INSTITUTE OF TECHNOLOGY   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHAGAS DISEASE; COMMUNITY ACQUIRED PNEUMONIA; CONVALESCENCE; EVOLUTION; GALLBLADDER DISEASE; HISTORY OF MEDICINE; HUMAN; IMMUNITY; INFECTION RISK; INJURY; LIPID DIET; METABOLIC SYNDROME X; MORTALITY RATE; NONHUMAN; OBESITY; PERITONITIS; POSTOPERATIVE COMPLICATION; REVIEW; RISK REDUCTION; SEPSIS; SURVIVAL; TUBERCULOSIS;

EID: 85014147304     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2016.00211     Document Type: Review

References (60)

1. Chiu M, Austin PC, Manuel DG, Shah BR, Tu JV. (2011) Deriving ethnic-specific BMI cutoff points for assessing diabetes risk. Diabetes Care. 34(8):1741-48.
2. Roth J. (2009) Evolutionary speculation about tuberculosis and the metabolic and inflammatory processes of obesity. JAMA. 301(24):2586-88.
3. Roth J, Szulc AL, Danoff A. (2011) Energy, evolution, and human diseases: an overview. Am J Clin Nutr. 93(4):S-875-83.
4. Schneeweiss S, Setoguchi S, Weinblatt ME, et al. (2007) Anti-tumor necrosis factor alpha therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis. Arthritis Rheum. 56(6):1754-64.
5. Bernatsky S, Hudson M, Suissa S. (2007) Anti-rheumatic drug use and risk of serious infections in rheumatoid arthritis. Rheumatology (Oxford). 46(7):1157-60.
6. Keane J, Gershon S, Wise RP, et al. (2001) Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N. Engl. J. Med. 345(15):1098-104.
7. Cegielski JP, McMurray DN. (2004) The relationship between malnutrition and tuberculosis: evidence from studies in humans and experimental animals. Int. J. Tuberc. Lung Dis. 8(3):286-98.
8. Tverdal A. (1986) Body mass index and incidence of tuberculosis. Eur. J. Respir. Dis. 69(5):355-62.
9. Edwards LB, Livesay VT, Acquaviva FA, Palmer CE. (1971) Height, weight, tuberculous infection, and tuberculous disease. Arch. Environ. Health. 22(1):106-12.
10. Lönnroth K, Williams BG, Cegielski P, Dye C. (2010) A consistent log-linear relationship between tuberculosis incidence and body mass index. Int. J. Epidemiol. 39(1):149-55.
11. Leung CC, Lam TH, Chan WM, et al. (2007) Lower risk of tuberculosis in obesity. Arch. Intern. Med. 167(12):1297-1304.
12. Cegielski JP, Arab L, Cornoni-huntley J. (2012) Nutritional risk factors for tuberculosis among adults in the United States, 1971-1992. Am. J. Epidemiol. 176(5):409-22.
13. Osler W, McCrae T. (1920) The Principles and Practice of Medicine: Designed for the Use of Practitioners and Students of Medicine. 9th Rev. Ed. New York, London: D. Appleton and Company. 1168 pp.
14. Jain S, Self WH, Wunderink RG, et al. (2015) Community-acquired pneumonia requiring hospitalization among U.S. adults. N. Engl. J. Med. 373(5):415-27.
15. José RJ, Periselneris JN, Brown JS. (2015) Community-acquired pneumonia. Curr. Opin. Pulm. Med. 21(3):212-18.
16. Regev-Yochay G, Raz M, Dagan R, et al. (2004) Nasopharyngeal carriage of Streptococcus pneumoniae by adults and children in community and family settings. Clin. Infect. Dis. 38(5):632-39.
17. Kahlon S, Eurich DT, Padwal RS, et al. (2013) Obesity and outcomes in patients hospitalized with pneumonia. Clin. Microbiol. Infect. 19(8):709-16.
18. Corrales-Medina VF, Valayam J, Serpa JA, Rueda AM, Musher DM. (2011) The obesity paradox in community-acquired bacterial pneumonia. Int. J. Infect. Dis. 15(1):e54-57.
19. King P, Mortensen EM, Bollinger M, et al. (2013) Impact of obesity on outcomes for patients hospitalised with pneumonia. Eur. Respir. J. 41(4):929-34.
20. Singanayagam A, Singanayagam A, Chalmers JD. (2013) Obesity is associated with improved survival in community-acquired pneumonia. Eur. Respir. J. 42(1):180-87.
21. Inoue Y, Koizumi A, Wada Y, Hiroyasu I, et al. (2007) Risk and protective factors related to mortality from pneumonia among middle-aged and elderly community residents: the JACC study. J. Epidemiol. 17(6):194-202.
22. Tejera A, Santolaria F, Diez ML, et al. (2007) Prognosis of community acquired pneumonia (CAP): value of triggering receptor expressed on myeloid cells-1 (TREM-1) and other mediators of the inflammatory response. Cytokine. 38(3):117-23.
23. Prescott HC, Chang VW, O’Brien JM, Langa KM, Iwashyna TJ. (2014) Obesity and 1-year outcomes in older Americans with severe sepsis. Crit. Care Med. 42(8):1766-74.
24. Wacharasint P, Boyd JH, Russell JA, Walley KR. (2013) One size does not fit all in severe infection: obesity alters outcome, susceptibility, treatment, and inflammatory response. Crit. Care. 17(3):R122.
25. Wurzinger B, Dünser MW, Wohlmuth C, et al. (2010) The association between body-mass index and patient outcome in septic shock: a retrospective cohort study. Wien Klin. Wochenschr. 122(1-2):31-36.
26. Trivedi V, Bavishi C, Jean R. (2015) Impact of obesity on sepsis mortality: A systematic review. J. Crit. Care. 30(3):518-24.
27. Machado FS, Dutra WO, Esper L, Tanowitz HB, et al. (2012) Current understanding of immunity to Trypanosoma cruzi infection and pathogenesis of Chagas disease. Semin. Immunopathol. 34(6):753-70.
28. Beleigoli AM, Ribeiro AL, Diniz Mde F, Lima-costa MF, Boersma E. (2013) The “obesity paradox” in an elderly population with a high prevalence of Chagas disease: the 10-year follow-up of the Bambuí (Brazil) Cohort Study of Aging. Int. J. Cardiol. 166(2):523-26.
29. Stewart L, Griffiss JM, Jarvis GA, Way LW. (2012) The association between body mass index and severe biliary infections: a multivariate analysis. Am. J. Surg. 204(5):574-79.
30. Bang CS, Yoon JH, Kim YJ, et al. (2014) Clinical impact of body mass index on bactibilia and bacteremia. BMC Gastroenterol. 14:104.
31. Utzolino S, Ditzel CM, Baier PK, Hopt UT, Kaffarnik MF. (2014) The obesity paradox in surgical intensive care patients with peritonitis. J. Crit. Care. 29(5):887.e1-5.
32. Brima W, Eden DJ, Mehdi SF, et al. (2015) The brighter (and evolutionarily older) face of the metabolic syndrome: evidence from Trypanosoma cruzi infection in CD-1 mice. Diabetes Metab. Res. Rev. 31(4):346-59.
33. Nagajyothi F, Weiss LM, Zhao D, et al. (2014) High fat diet modulates Trypanosoma cruzi infection associated myocarditis. PLoS Negl. Trop. Dis. 8(10):e3118.
34. Tschöp J, Nogueiras R, Haas-lockie S, et al. (2010) CNS leptin action modulates immune response and survival in sepsis. J. Neurosci. 30(17):6036-47.
35. Siegl D, Annecke T, Johnson BL, et al. (2014) Obesity-induced hyperleptinemia improves survival and immune response in a murine model of sepsis. Anesthesiology. 121(1):98-114.
36. Faggioni R, Feingold KR, Grunfeld C. (2001) Leptin regulation of the immune response and the immunodeficiency of malnutrition. FASEB J. 15(14):2565-71.
37. Allison MB, Myers MG. (2014) Twenty years of leptin: connecting leptin signaling to biological function. J. Endocrinol. 223(1):T25-35.
38. Huttunen R, Syrjänen J. (2013) Obesity and the risk and outcome of infection. Int. J. Obes. (Lond.). 37(3):333-40.
39. Flegal KM, Kit BK, Orpana H, Graubard BI. (2013) Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA. 309(1):71-82.
40. Fezeu L, Julia C, Henegar A, et al. (2011) Obesity is associated with higher risk of intensive care unit admission and death in influenza A (H1N1) patients: a systematic review and meta-analysis. Obes. Rev. 12(8):653-59.
41. Cui W, Zhao H, Lu X, et al. (2010) Factors associated with death in hospitalized pneumonia patients with 2009 H1N1 influenza in Shenyang, China. BMC Infect. Dis. 10:145.
42. Yang L, Chan KP, Lee RS, et al. (2013) Obesity and influenza associated mortality: evidence from an elderly cohort in Hong Kong. Prev. Med. 56(2):118-23.
43. Kok J, Blyth CC, Foo H, et al. (2013) Viral pneumonitis is increased in obese patients during the first wave of pandemic A(H1N1) 2009 virus. PLoS ONE. 8(2):e55631.
44. Jarčuška P, Janičko M, Kružliak P, et al. (2014) Hepatitis B virus infection in patients with metabolic syndrome: a complicated relationship. Results of a population based study. Eur. J. Intern. Med. 25(3):286-91.
45. Wong GL, Chan HL, Yu Z, et al. (2014) Coincidental metabolic syndrome increases the risk of liver fibrosis progression in patients with chronic hepatitis B: a prospective cohort study with paired transient elastography examinations. Aliment. Pharmacol. Ther. 39(8):883-93.
46. Charlton MR, Pockros PJ, Harrison SA. (2006) Impact of obesity on treatment of chronic hepatitis C. Hepatology. 43(6):1177-86.
47. Zhou Y, Cui Y, Deng H, Yu J. (2014) Association between hepatitis B virus infection and metabolic syndrome: a retrospective cohort study in Shanghai, China. BMC Public Health. 14:516.
48. Prieto-Alhambra D, Premaor MO, Aviles FF, et al. (2014) Relationship between mortality and BMI after fracture: a population-based study of men and women aged ≥ 40 years. J. Bone Miner. Res. 29(8):1727-44.
49. Valentijn TM, Galal W, Tjeertes EK, Hoeks SE, Verhagen HJ, Stolker RJ. (2013) The obesity paradox in the surgical population. Surgeon. 11(3):169-76.
50. Valentijn TM, Galal W, Hoeks SE, Van Gestel YR, Verhagen HJ, Stolker RJ. (2013) Impact of obesity on postoperative and long-term outcomes in a general surgery population: a retrospective cohort study. World J. Surg. 37(11):2561-68.
51. Zhu S, Ashok M, Li J, et al. (2009) Spermine protects mice against lethal sepsis partly by attenuating surrogate inflammatory markers. Mol. Med. 15(7-8):275-82.
52. Matsuda A, Jacob A, Wu R, et al. (2011) Milk fat globule-EGF factor VIII in sepsis and ischemia-reperfusion injury. Mol. Med. 17(1-2): 126-33.
53. Hoque R, Farooq A, Mehal WZ. (2013) Sterile inflammation in the liver and pancreas. J. Gastroenterol. Hepatol. 28 Suppl 1:61-67.
54. Fleshner M. (2013) Stress-evoked sterile inflammation, danger associated molecular patterns (DAMPs), microbial associated molecular patterns (MAMPs) and the inflammasome. Brain Behav. Immun. 27(1):1-7.
55. Chen GY, Nuñez G. (2010) Sterile inflammation: sensing and reacting to damage. Nat. Rev. Immunol. 10(12):826-37.
56. Kubes P, Mehal WZ. (2012) Sterile inflammation in the liver. Gastroenterology. 143(5):1158-72.
57. Land WG. (2015) The Role of Damage-Associated Molecular Patterns (DAMPs) in Human Diseases, Part II: DAMPs as diagnostics, prognostics and therapeutics in clinical medicine. Sultan Qaboos Univ. Med. J. 15(2):e157-70.
58. Rothstein WG. (1995) Trends in mortality in the twentieth century. In: Readings in American Health Care: Current Issues in Socio-Historical Perspective. Madison: University of Wisconsin Press. p. 72.
59. Data available at: http://www.cdc.gov/nchs/data/nvsr/nvsr50/nvsr50_15. Accessed July 21, 2016.
60. Reaven G, Abbasi F, McLaughlin T. (2004) Obesity, insulin resistance, and cardiovascular disease. Recent Prog. Horm. Res. 59:207-23.